GlassScriptPhysician profile
Michael H Hsia
NPI 1487879151
$3,120.17
in general payments reported to CMS, 2019-2025
29 companies · $220 in 2025
The $220 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $844 · 2020: $112 · 2021: $464 · 2022: $646 · 2023: $650 · 2024: $184 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $953 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $953.35 |
| Education | $101.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $633.22 | 2019-2024 | Myrbetriq, Xtandi |
| Boston Scientific Corporation | $385.71 | 2019-2024 | Moses 550 D\F\L, Rezum Generator |
| Medtronic, INC. | $218.11 | 2021-2025 | Interstim |
| Urogen Pharma, INC. | $197.97 | 2021-2023 | Jelmyto |
| Medtronic USA, INC. | $192.88 | 2019 | |
| Janssen Biotech, INC. | $175.82 | 2019-2022 | |
| Procept Biorobotics Corporation | $142.42 | 2023 | Aquabeam Robotic System |
| Intuitive Surgical, INC. | $131.43 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $128.24 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $124.29 | 2023-2024 | Gemtesa |
| Calyxo, INC. | $109.97 | 2025 | Cvac Aspiration System |
| Abbvie INC. | $97.94 | 2022-2023 | |
| Allergan, INC. | $94.93 | 2019-2022 | |
| Urovant Sciences INC | $67.25 | 2021-2022 | |
| Coloplast Corp | $64.40 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $50.57 | 2021-2022 | |
| Blue Earth Diagnostics | $48.98 | 2021-2022 | |
| Acerus Pharmaceuticals Corporation | $46.66 | 2021-2022 | |
| Tolmar, INC. | $28.46 | 2023 | |
| Teleflex LLC | $24.83 | 2021 | |
| Merck Sharp & Dohme LLC | $24.27 | 2022 | |
| Accord Healthcare, INC. | $21.62 | 2022 | |
| Travere Therapeutics, INC. | $17.89 | 2019-2025 | Thiola |
| Olympus America INC. | $17.18 | 2023 | Itind System |
| Foundation Medicine, INC. | $16.74 | 2022 | |
| Axonics, INC. | $15.93 | 2023 | Axonics |
| Myriad Genetic Laboratories, INC. | $15.25 | 2021 | |
| Antares Pharma, INC. | $14.43 | 2019 | |
| Endo Pharmaceuticals INC. | $12.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hsia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.